Thermo Fisher reported 2025 revenue of $44.6 billion and Q1 2026 revenue of $11.0 billion. The thesis depends on biopharma demand, instrument and consumables mix, diagnostics normalization, margin durability, M&A integration and cash conversion.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-19 · Issuer identity, ticker, exchange and CIKSEC APISEC submissions APIRetrieved 2026-05-19 · Filing chronology and company identitySEC XBRL APISEC companyfacts APIRetrieved 2026-05-19 · Financial statement cross-checksAnnual reportFY2025 Form 10-K filed 2026-02-262026 · Annual business, risk and financial baselineQuarterly reportForm 10-Q filed 2026-05-012026 · Latest interim financial baselineEarnings release exhibitQ1 2026 earnings exhibit filed 2026-04-232026 · Recent management-reported earnings contextCurrent reportForm 8-K filed 2026-04-232026 · Recent filing chronologyProxy statementDEF 14A filed 2026-04-072026 · Governance and incentive context